Search Result "DPD deficiency"
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 â Where Do We Stand?
Journal: Clinical Cancer Drugs
Volume: 4 Issue: 2 Year: 2017 Page: 74-81
Author(s): Manon Launay,Joseph Ciccolini,Anne Rodallec,Claire Fournel,Florence Duffaud,Sebastien Salas,Bruno Lacarelle
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
Journal: Clinical Cancer Drugs
Volume: 4 Issue: 2 Year: 2017 Page: 122-128
Author(s): Carmello Blanquicett,Manon Launay,Joseph Ciccolini,Claire Fournel,Charlotte Dupuis,Nicolas Fakhry,Florence Duffaud,Sebastien Salas,Bruno Lacarelle
Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency
Journal: Current Pharmacogenomics
Volume: 5 Issue: 1 Year: 2007 Page: 31-38
Author(s): Hui-Hua Hsiao, Sheng-Fung Lin
Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 14 Year: 2017 Page: 2028-2034
Author(s): Marzia Del Re,Giuliana Restante,Antonello Di Paolo,Stefania Crucitta,Eleonora Rofi,Romano Danesi
Fluoropyrimidine Toxicity: the Hidden Secrets of DPYD
Journal: Current Drug Metabolism
Volume: 25 Issue: 2 Year: 2024 Page: 91-95
Author(s): Vangelis G. Manolopoulos
Dependence of Cell Survival on Correlative Activities of Xanthine Oxidase and Dihydopyrimidine Dehydrogenase in Human Brain-Derived Cell Culture
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 108-113
Author(s): Kristine E. Danielyan
Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1713-1719
Author(s): Christian Woloch,Antonello Di Paolo,Hafedh Marouani,Guido Bocci,Joseph Ciccolini,Bruno Lacarelle,Romano Danesi,Athanassios Iliadis
Pharmacogenetics of Colon Cancer and Potential Implications for 5- Fluorouracil-Based Chemotherapy
Journal: Current Pharmacogenomics
Volume: 4 Issue: 1 Year: 2006 Page: 57-67
Author(s): R. Mauritz, G. J. Peters
Dihydropyrimidine Dehydrogenase Genotyping and Phenotyping for 5- Fluorouracil Dysmetabolism: Moving Towards Personalized Chemotherapy in Patients with Cancer
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 7 Issue: 4 Year: 2009 Page: 275-283
Author(s): Moritz Eidens, Stefan Prause, Alexander Weise, Marco Klemm, Matthias M. Weber, Andreas Pfutzner
A Carboxylesterase 2 Gene Polymorphism as Predictor of Capecitabine on Response and Time to Progression
Journal: Current Drug Metabolism
Volume: 9 Issue: 4 Year: 2008 Page: 336-343
Author(s): N. Ribelles, J. Lopez-Siles, A. Sanchez, E. Gonzalez, M. J. Sanchez, F. Carabantes, P. Sanchez-Rovira, A. Marquez, R. Duenas, I. Sevilla, E. Alba